resultados de evaluacion de genetica

"Leukemia, Myeloid, Chronic"[MeSH] AND "Polymerase Chain Reaction"[MeSH]

sindi lorena ñañez cod 2005202488

1: Gan GG, Pasagna JF, Eow GI, Nadarajan VS.
Chronic neutrophilic leukaemia.
Singapore Med J. 2007 Mar;48(3):e74-6.
PMID: 17342275 [PubMed - indexed for MEDLINE]

2: Weisser M, Tischer J, Schnittger S, Schoch C, Ledderose G, Kolb HJ.
A comparison of donor lymphocyte infusions or imatinib mesylate for patients
with chronic myelogenous leukemia who have relapsed after allogeneic stem
cell
transplantation.
Haematologica. 2006 May;91(5):663-6. Epub 2006 Apr 19.
PMID: 16627251 [PubMed - indexed for MEDLINE]

3: Colombat M, Fort MP, Chollet C, Marit G, Roche C, Preudhomme C, Reiffers
J,
Praloran V, Mahon FX.
Molecular remission in chronic myeloid leukemia patients with sustained
complete cytogenetic remission after imatinib mesylate treatment.
Haematologica. 2006 Feb;91(2):162-8.
PMID: 16461299 [PubMed - indexed for MEDLINE]

4: Martinelli G, Iacobucci I, Rosti G, Pane F, Amabile M, Castagnetti F,
Cilloni D, Soverini S, Testoni N, Specchia G, Merante S, Zaccaria A,
Frassoni F,
Saglio G, Baccarani M.
Prediction of response to imatinib by prospective quantitation of BCR-ABL
transcript in late chronic phase chronic myeloid leukemia patients.
Ann Oncol. 2006 Mar;17(3):495-502. Epub 2006 Jan 10.
PMID: 16403813 [PubMed - indexed for MEDLINE]

5: de Rijke B, van Horssen-Zoetbrood A, Beekman JM, Otterud B, Maas F,
Woestenenk R, Kester M, Leppert M, Schattenberg AV, de Witte T, van de
Wiel-van
Kemenade E, Dolstra H.
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T
lymphocyte
response associated with remission of chronic myeloid leukemia.
J Clin Invest. 2005 Dec;115(12):3506-16.
PMID: 16322791 [PubMed - indexed for MEDLINE]

_________________________________________________________________
MSN Amor: busca tu ½ naranja http://latam.msn.com/amor/